Skip to main content
KOMIPHARM INTERNATIONAL CO., LTD. logo

KOMIPHARM INTERNATIONAL CO., LTD. — Investor Relations & Filings

Ticker · 041960 ISIN · KR7041960006 KO Manufacturing
Open in API
Filings indexed 326 across all filing types
Latest filing 2019-01-14 Director's Dealing
Country KR South Korea
Listing KO 041960

About KOMIPHARM INTERNATIONAL CO., LTD.

https://komipharm.co.kr/en/

Komipharm International Co., Ltd. is a biopharmaceutical company engaged in the development, manufacturing, and sale of products for both animal and human health. Its Animal Health Division provides a portfolio of veterinary vaccines, pharmaceuticals, and disinfectants. The company's Pharmaceutical Division is dedicated to the research and development of novel therapeutic agents, with key research areas including anticancer drugs and treatments for cancer-related pain and autoimmune diseases. Leveraging extensive experience, the company focuses on intensive R&D to expand its presence in the global bio-industry.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when an executive or major shareholder changes their ownership stake in a company. This specific document details the resignation of an executive (Kim Soo-jung) and the subsequent change in their shareholding status. This falls under the category of 'Director's Dealing' (DIRS), which covers insider transactions and changes in ownership by company directors and executives.
2019-01-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the shareholding changes of a director/major shareholder (Yang Yong-jin) of KomiPharm. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports insider transactions and changes in ownership status.
2019-01-04 Korean
전환가액의조정(제10회차, 제11회차, 제12회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the adjustment of conversion prices for convertible bonds (CB) due to a bonus issue (free capital increase). This type of filing, which details changes to the capital structure and conversion terms of financial instruments, falls under the 'Capital/Financing Update' category as it directly relates to the company's financing activities and debt-to-equity conversion terms.
2019-01-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Yang Yong-jin) of KomiPharm. This type of filing is a standard regulatory requirement for reporting insider transactions (director's dealings) in South Korea. It details the change in share ownership (increase of 15,000 shares) by a company director. Therefore, it falls under the 'Director's Dealing' category.
2018-12-27 Korean
권배락(무상증자 및 배당)
Share Issue/Capital Change Classification · 95% confidence The document is a short notice regarding '권배락' (ex-rights/ex-dividend date) for K-Pharma, detailing the date, reason (bonus issue and dividend), and reference price. This type of corporate action announcement regarding capital changes and dividends fits the 'Share Issue/Capital Change' category as it relates to the impact of a bonus issue on share structure.
2018-12-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership changes of a director/major shareholder (Yang Yong-jin) of KomiPharm. This type of filing is specifically categorized as a 'Director's Dealing' or 'Insider Trading' report, which corresponds to the 'DIRS' code in the provided schema.
2018-12-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.